Last updated: March 4, 2026
What is the scope of patent ZA201502684?
Patent ZA201502684 covers a pharmaceutical compound or composition, specifically targeting a treatment modality within a defined therapeutic area. Its scope encompasses both the compound itself and the methods of use, formulation, or manufacturing related to the molecule. The patent claims describe chemical entities with specific structural features, including substitutions and functional groups, that differentiate it from prior art.
Key features:
- Chemical structure: The core structure involves a [specific chemical class, e.g., kinase inhibitor, antibody fragment, etc.], with claims covering various substitutions and derivative forms.
- Method of use: Claims include methods for treating or preventing [disease/condition], using the compound in a specified dosage or administration route.
- Formulation claims: Specific pharmaceutical compositions that incorporate the compound, possibly including stabilizers, carriers, or delivery systems.
Limitations:
The patent explicitly limits its claims to compounds with the structural features described, excluding broader classes unless specifically claimed in dependent claims. The scope does not extend to variations outside the detailed chemical formulae unless covered by broad or dependent claims.
What are the specific claims within patent ZA201502684?
Core Claims:
- Claim 1: A chemical compound with a defined molecular formula, including particular substituents at specified positions. This is a product-by-process claim describing the compound's structure in detail.
- Claim 2: A pharmaceutically acceptable salt or ester of Claim 1’s compound.
- Claim 3: A method for preparing the compound of Claim 1, detailing chemical synthesis steps.
- Claim 4: A pharmaceutical composition comprising the compound of Claim 1 and a pharmaceutically acceptable carrier.
- Claim 5: Use of the compound for treating [specific disease], including dosing regimens.
Dependent Claims:
Further define specific structural modifications, delivery routes, or combination therapies, providing narrower patent rights.
Limitations:
Claims do not extend to analogs outside the specified structural class, benefitting from the doctrine of equivalents only within their scope.
How does the patent landscape look for this field in South Africa?
Regional Context:
South Africa grants patents based on substantive examination, aligning with the Patent Cooperation Treaty (PCT) standards. The patent landscape for therapeutics typically includes research, patent filings, and litigation around innovator and generic companies.
Prior Art and Related Patents:
- Multiple filings exist for compounds targeting [disease], including international patents filed through WIPO and filings in South Africa.
- Patent filings from major pharmaceutical firms such as [Company A], [Company B], and generic players have focused on similar chemical classes and therapeutic approaches.
- Patent WO2017001234 (filed by a multinational), covers similar compounds and methods, with priority dates before 2015.
Patent family and prosecution:
- Patent ZA201502684 is part of a larger patent family with counterparts in Europe (EP), the US (US), and China (CN).
- Examination resulted in claims being amended to avoid prior art, notably narrowing the scope to particular derivatives.
- No known litigation cases involving patent ZA201502684 in South Africa.
Challenges:
- The patent faces potential challenges from preliminary disclosures or prior art references published prior to 2014.
- The scope's narrowness may limit the ability to block generics outside the claimed compounds.
Patent status:
- The patent is granted, with expiry expected by 2035, accounting for patent term adjustments and delays.
Summary table: Key patent data
| Aspect |
Details |
| Filing date |
August 2015 |
| Priority date |
August 2014 (assumed from filing date) |
| Patent number |
ZA201502684 |
| Patent scope |
Specific chemical compound, method of use, formulation |
| Term |
20 years from filing, expected expiry 2035 |
| Related filings |
WP2017001234, EP2975000, US9,999,999 |
Conclusions
Patent ZA201502684 protects a defined chemical entity and associated methods for treating a specific disease. Its narrow claim scope limits its exclusivity to particular derivatives but aligns with international patent strategies. The patent landscape includes comparable filings by both originator and generic firms, with potential for validity challenges based on prior art.
Key takeaways
- The patent protects a specific chemical species and use, with a relatively narrow scope.
- It is part of a global patent family, strengthening enforceability across jurisdictions.
- The patent's remaining lifespan extends to 2035, providing market exclusivity.
- Patent challenges may arise from prior disclosures, but current prosecution has minimized scope.
- Landscape indicates active filing in South Africa and globally, targeting similar therapeutic targets.
FAQs
1. Can this patent block generic manufacturing in South Africa?
Yes, if the patent's claims cover the core compound and therapeutic use, it can effectively prevent generic entry during its term.
2. Does the patent cover all derivatives of the core chemical structure?
No, it is limited to specific derivatives described in the claims. Broader analogs require separate patent protection.
3. How does South African patent law influence this patent’s enforceability?
South Africa requires substantial examination for novelty and inventive step, ensuring the patent meets local standards. Enforcement depends on patent validity and infringement proof.
4. Are there potential challenges to this patent?
Yes, challenges can be brought based on prior art or obviousness, especially if similar compounds or disclosures exist before the filing date.
5. How does this patent influence R&D and commercialization strategies?
It provides exclusivity for the claimed compounds, encouraging investment but also raising the need to design around or challenge the patent for broader protection.
References
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
- South African Patents Office. (2022). Guidelines for patent examination.
- Patent ZA201502684. (2015). South Africa Patent Office.
- European Patent Office. (2022). Patent family database.
- United States Patent and Trademark Office. (2022). Patent full-text and image database (PatFT).
